Although half a million doses of Novavax's vaccine have now been distributed to states, following its authorization last month, just 9,700 doses of Novavax's COVID-19 vaccine have been administered across the country, according to federal data.
Last month, officials from the Centers for Disease Control and Prevention signed off on the use of Novavax's COVID-19 vaccine for Americans ages 18 years and older, making it the fourth COVID-19 vaccine to be made available to the American public.
However, experts say that although overall uptake may still be limited, there some Americans who have been vaccinated with Moderna, Pfizer, or Johnson & Johnson's COVID-19 vaccines, may feel more inclined to receive Novavax's booster.